Microvascular inflammation in the kidney transplant, beyond acute antibody-mediated rejection
Microvascular inflammation (MVI) is a central feature of allograft rejection, traditionally associated with antibody-mediated rejection (AMR), but its mechanisms and clinical impact extend beyond this framework. This review highlights recent updates in the Banff classification, insights into the mec...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Article (Journal) |
| Lenguaje: | inglés |
| Publicado: |
May 2026
|
| In: |
Current opinion in nephrology and hypertension
Year: 2026, Volumen: 35, Número: 3, Pages: 316-322 |
| ISSN: | 1062-4813 |
| DOI: | 10.1097/MNH.0000000000001165 |
| Acceso en línea: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1097/MNH.0000000000001165 Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/co-nephrolhypertens/abstract/2026/05000/microvascular_inflammation_in_the_kidney.7.aspx 
|
| Notas de Autor: | Aurélie Sannier, Louise Benning, Alexandre Loupy |
| Sumario: | Microvascular inflammation (MVI) is a central feature of allograft rejection, traditionally associated with antibody-mediated rejection (AMR), but its mechanisms and clinical impact extend beyond this framework. This review highlights recent updates in the Banff classification, insights into the mechanisms underlying MVI, and how these developments may refine diagnostic approaches and guide the development of therapeutic strategies |
|---|---|
| Notas: | Gesehen am 24.06.2026 |
| Descripción Física: | Online Resource |
| ISSN: | 1062-4813 |
| DOI: | 10.1097/MNH.0000000000001165 |